Looking at Alzheimer’s Disease Pathogenesis from the Nuclear Side
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the most common form of dementia. It is biologically characterized by the deposition of extracellular amyloid-β (Aβ) senile plaques and intracellular neurofibrillary tangles, constituted by hyperphosphorylated tau protein. The key...
Main Authors: | Laura D’Andrea, Ramona Stringhi, Monica Di Luca, Elena Marcello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/9/1261 |
Similar Items
-
Lipid rafts and Alzheimer’s disease: protein-lipid interactions and perturbation of signalling
by: David A. Hicks, et al.
Published: (2012-06-01) -
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
by: Laura Ibanez, et al.
Published: (2021-08-01) -
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
by: Long Wang, et al.
Published: (2023-11-01) -
Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
by: Stephanie R. Oatman, et al.
Published: (2023-01-01) -
How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer’s disease risk? A novel integrative model
by: Jaisalmer de Frutos Lucas, et al.
Published: (2023-01-01)